A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India

International Journal of Gynecological Cancer

Volumn 17, Issue 1, 2007, Pages 107-117

  Laikangbam, P ^a   Sengupta, S ^a   Bhattacharya, P ^a   Duttagupta, C ^b   Dhabali Singh, Th ^c   Verma, Y ^d   Roy, S ^e   Das, R ^f   Mukhopadhyay, S ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b Institute of Technology and Marine Engineering   (India)

^c Babina Diagnostic Centre   (India)

^d Sir Thutob Namgyal Memorial Hospital   (India)

^e Quadra Diagnostic Centre   (India)

^f Child in Need Institute   (India)

Author keywords

Age related prevalence; General populations; HPV infection; Northeast India

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; AGE FACTORS; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INDIA; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE;

EID: 33846804479     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00827.x     Document Type: Article

References (41)

1. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796-802.
2. Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cancer worldwide. J Pathol 1999;189:12-9.
3. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
4. Duttagupta C, Sengupta S, Roy M et al. Oncogenic human papillomavirus (HPV) infection and uterine cervical cancer: a screening strategy in the perspective of rural India. Eur J Cancer Prev 2002;11:447-56.
5. Franceschi S, Rajkumar R, Snijders PJF et al. Papillomavirus infection in rural women in Southern India. Br J Cancer 2005;92:601-6.
6. Sowjanya AP, Jain M, Poli UR et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types and invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 2005;5:116.
7. Arora R, Kumar A, Prusty BK et al. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Euro J Obstetrics & Gynecol 2005;121:104- 9.
8. Basu A, Mukherjee N, Roy S et al. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 2003;13:2277-90.
9. Duttagupta C, Sengupta S, Roy M et al. Are Muslim women less susceptible to oncogenic human papillomavirus infection?: a study from rural eastern India. Int J Gynecol Cancer 2004;14:293-303.
10. The 1991 Bethesda workshop: the revised Bethesda System for reporting cervical/vaginal cytologic diagnosis: report of the 1991 Bethesda workshop. J Reprod Med 1992;37:383-6.
11. Miller SA, Dykes D, Polesky HK. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998;16:1215.
12. Ting Y, Manos MM. Detection and typing of genital human papillomavirus. In: Innis MA, Gelfond DH, Sninsky JJ, White TJ, eds. PCR protocol: a guide to methods and applications. San Diego, CA: Academic press 1990:356-67.
13. Fontaine J, Gravitt P, Duh L-M et al. High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens. Cancer Epidemiol Biomarkers Prev 2005;14:2200-07.
14. Tachezy R, Van Ranst MA, Cruz Y et al. Analysis of short novel human papillomavirus sequences. Biochem res commun 1994;204:820-7.
15. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCON 2000: cancer incidence, mortality and prevalence worldwide, version 1.0; IARC Cancer base No. 5. Lyon, France: IARC Press, 2000.
16. World Health Organization. Non communicable diseases in South-East Asia region. A profile. New Delhi, India: World Health Organization, 2002.
17. Sharma DC. HPV vaccine trial may take place in India. Lancet Oncol 2002;3:649.
18. Franceschi S, Rajkumar R, Vacarella S et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J cancer 2003;107:127-33.
19. Schellekens MC, Dijkman A, Aziz MF et al. Single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 2004;93:49-53.
20. Ngelangel C, Munoz N, Bosch FX et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90:43-9.
21. Chicharen S, Herrero R, Munoz N et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
22. Garg S, Sharma N, Bhalla P et al. Reproductive morbidity in an Indian urban slum: need for health action. Available at: sti.bmjjournals.com. Accessed March 3, 2006.
23. Garg S, Sharma N, Bhalla P et al. Reproductive morbidity in an Indian urban slum: need for health action. Paper presented at the Workshop on Reproductive Health in India: New Evidence and Issues; February 28 to March 1, 2000; Pune.
24. Clifford GM, Gallus S, Herrero R et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International agency for research on cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
25. Thomas JO, Herrero R, Omigbodum AA et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45.
26. Herrero R, Hildesheim A, Bratti C et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-73.
27. Lazcano-Ponce E, Herrero R, Munoz N et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
28. Cuzick J, Beverly E, Ho L et al. Human papillomavirus testing in older women. Br J Cancer 1999;81:554-8.
29. Sankarnarayan R, Nene BM, Dinshaw KA et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005;116:617-23.
30. Sankarnarayan R, Chatterji R, Shastri SS et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 2004;112:341-7.
31. Bosch FX, de Sanjose S. Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monographs 2003;31:3-13.
32. Petignat P, Faltin D, Goffin F et al. Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with low incidence of cervical carcinoma. Cancer 2005;105:126-32.
33. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K. Distribution of human papillomavirus types in Thin Prep Papnicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006;106:1054-64.
34. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
35. Molano M, van den Brule A, Plummer M et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population based, 5-year follow-up study. Am J Epidemiol 2003;158:486-94.
36. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1157-64.
37. Clifford GM, Smith JS, Aguardo T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-05.
38. Woodman CB, Collins S, Winter H et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
39. Khan MJ, Castle PE, Lorincz AT et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-8.
40. Herrero R, Castle PE, Schiffman M et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infectious Diseases 2005;191:1796-807.
41. National AIDS Control Organization. Observed HIV prevalence levels state wise: 1998-2004. Available at: http://www.nacoonline.org/factsnfigures/ indianscenario.pdf. 2005. Accessed March 19, 2006.